Revenue from operations rose to Rs. 23,637 million for the three months ended December 31, 2025
Revenue from operations surged 30% year-on-year to Rs. 68,645 million
The company has commissioned a new plant at Khanna (Punjab), which has begun commercial production
Anand Chemiceutics serves over 1,500 laboratories, hospitals, and government institutions
Launched in August 2025, GSK India’s Oncology business is rapidly gaining momentum
The company’s EBITDA margin remained resilient above 20%
The board highlighted ongoing investments in Radiopharma, CDMO Sterile Injectables, and CRDMO businesses
HCG clinicians contributing to one of the largest bodies of oncology research from India
Call it one of the most striking turnarounds in the Indian pharma sector this fiscal year
Subscribe To Our Newsletter & Stay Updated